Raysearch Laboratories Ab Stock Cash Per Share
| RAY-B Stock | SEK 208.00 1.00 0.48% |
RaySearch Laboratories AB fundamentals help investors to digest information that contributes to RaySearch Laboratories' financial success or failures. It also enables traders to predict the movement of RaySearch Stock. The fundamental analysis module provides a way to measure RaySearch Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RaySearch Laboratories stock.
RaySearch |
RaySearch Laboratories AB Company Cash Per Share Analysis
RaySearch Laboratories' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current RaySearch Laboratories Cash Per Share | 3.30 X |
Most of RaySearch Laboratories' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RaySearch Laboratories AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, RaySearch Laboratories AB has a Cash Per Share of 3.3 times. This is 6.25% lower than that of the Technology sector and notably higher than that of the Health Information Services industry. The cash per share for all Sweden stocks is 34.13% higher than that of the company.
RaySearch Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RaySearch Laboratories' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RaySearch Laboratories could also be used in its relative valuation, which is a method of valuing RaySearch Laboratories by comparing valuation metrics of similar companies.RaySearch Laboratories is currently under evaluation in cash per share category among its peers.
RaySearch Fundamentals
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.45 B | |||
| Shares Outstanding | 25.83 M | |||
| Shares Owned By Insiders | 4.00 % | |||
| Shares Owned By Institutions | 55.61 % | |||
| Price To Earning | 56.86 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 2.85 X | |||
| Revenue | 641.67 M | |||
| Gross Profit | 591.28 M | |||
| EBITDA | 197.36 M | |||
| Net Income | (47.31 M) | |||
| Cash And Equivalents | 102.53 M | |||
| Cash Per Share | 3.30 X | |||
| Total Debt | 491.9 M | |||
| Debt To Equity | 39.30 % | |||
| Current Ratio | 1.66 X | |||
| Book Value Per Share | 18.81 X | |||
| Cash Flow From Operations | 238.16 M | |||
| Earnings Per Share | (1.03) X | |||
| Target Price | 90.0 | |||
| Number Of Employees | 373 | |||
| Beta | 1.45 | |||
| Market Capitalization | 2.78 B | |||
| Total Asset | 1.74 B | |||
| Working Capital | 182 M | |||
| Current Asset | 262 M | |||
| Current Liabilities | 80 M | |||
| Z Score | 3.0 | |||
| Net Asset | 1.74 B |
About RaySearch Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RaySearch Laboratories AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RaySearch Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RaySearch Laboratories AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RaySearch Stock Analysis
When running RaySearch Laboratories' price analysis, check to measure RaySearch Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RaySearch Laboratories is operating at the current time. Most of RaySearch Laboratories' value examination focuses on studying past and present price action to predict the probability of RaySearch Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RaySearch Laboratories' price. Additionally, you may evaluate how the addition of RaySearch Laboratories to your portfolios can decrease your overall portfolio volatility.